Chirurgisches und perioperatives Management des Pankreaskarzinoms

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: Ass.-Prof. Dr. Klaus Sahora

Abteilung für Allgemeinchirurgie, Universitätsklinik für Chirurgie, Comprehensive Cancer Center Vienna, Medizinische Universität Wien


AutorIn: ao. Univ.-Prof. Dr. Martin Schindl

Abteilung für Allgemeinchirurgie, Universitätsklinik für Chirurgie, Comprehensive Cancer Center Vienna, Medizinische Universität Wien


AutorIn: o. Univ.-Prof. Dr. Michael Gnant

Abteilung für Allgemeinchirurgie, Universitätsklinik für Chirurgie, Comprehensive Cancer Center Vienna, Medizinische Universität Wien


Literatur:
1 Sosa JA et al., Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg 1998; 228:429–38
2 van Heek NT et al., Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 2005; 242:781–8, discussion 8-90
3 Tseng JF et al., The learning curve in pancreatic surgery. Surgery 2007; 141:694–701
4 Ichikawa T et al., Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997; 202:655–62
5 Tunaci M, Multidetector row CT of the pancreas. Eur J Radiol 2004; 52:18–30
6 van der Gaag NA et al., Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 2010; 362:129–37
7 Sewnath ME et al., A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002; 236:17–27
8 Watson WG, The surgical treatment of pancreatic and bile duct tumors. Pa Med J 1950; 53:700–2
9 Traverso LW, Longmire WP Jr, Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 1978; 146:959–62
10 Longmire WP Jr et al., The surgical treatment of pancreatic disease. Jpn J Surg 1978; 8:249–60
11 Takada T et al., Results of a pylorus-preserving pancreatoduodenectomy for pancreatic cancer: a comparison with results of the Whipple procedure. Hepatogastroenterology 1997; 44:1536–40
12 Seiler CA et al., Randomized prospective trial of pylorus-preserving vs. Classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 2000; 4:443–52
13 Yeo CJ et al., Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 2002; 236:355–66; discussion 66-8
14 Yeo CJ et al., Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 1999; 229:613–22; discussion 22-4
15 Michalski CW et al., Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 2007; 94:265–73
16 Tseng JF et al., Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004; 8:935–49; discussion 49-50
17 Riediger H et al., Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg 2006; 10:1106–15
18 Yekebas EF et al., En Bloc Vascular Resection for Locally Advanced Pancreatic Malignancies Infiltrating Major Blood Vessels: Perioperative Outcome and Long-term Survival in 136 Patients. Ann Surg 2008; 247:300–9
19 Hartwig W et al., Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg 2009; 250:81–7
20 Sahora K et al., A phase II trial of two durations of bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer. Anticancer Res 2014; 34:2377–84
21 Sahora K et al., NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer. Surgery 2011; 149:311–20
22 Sahora K et al., NeoGemTax: gemcitabine and docetaxel as neoadjuvant treatment for locally advanced nonmetastasized pancreatic cancer. World J Surg 2011; 35:1580–9

SO 04|2014

Herausgeber: Univ.-Prof. Dr. Christoph Zielinski, Univ.-Prof. Dr. Markus Raderer
Publikationsdatum: 2014-12-19